Dawei Chen
Impact in
- Oncology top 2%
- Cancer Immunotherapy and Biomarkers
- Lung Cancer Research Studies
- CAR-T cell therapy research
-
- Lung Cancer Treatments and Mutations
- Lung Cancer Diagnosis and Treatment
Papers in
- Oncology 59
- Cancer Immunotherapy and Biomarkers 32
- Lung Cancer Research Studies 16
- Inflammatory Biomarkers in Disease Prognosis 8
-
- Lung Cancer Diagnosis and Treatment 22
- Lung Cancer Treatments and Mutations 19
- Co-authors
- Zengfu Zhang (7 shared papers)Jinming Yu (5 shared papers)Xu Liu (3 shared papers)James W. Welsh (18 shared papers)Vivek Verma (17 shared papers)Hampartsoum B. Barsoumian (12 shared papers)María Angélica Cortez (11 shared papers)Roshal R. Patel (6 shared papers)
- Journals
- Frontiers in Oncology (6 papers)Frontiers in Immunology (5 papers)International Journal of Radiation Oncology*Biology*Physics (5 papers)Journal of Clinical Oncology (5 papers)Cancer Letters (4 papers)
- Partner nations
- ChinaUnited StatesTürkiye
In The Last Decade
Dawei Chen
80 papers receiving 2.3k citations
Dawei Chen's Hit Papers
Peers
Comparison fields: 5 of 100
- Oncology 1.5k
- Pulmonary and Respiratory Medicine 933
- Immunology 554
- Cancer Research 323
- Radiation 97
Countries citing papers authored by Dawei Chen
This map shows the geographic impact of Dawei Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dawei Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dawei Chen more than expected).
Fields of papers citing papers by Dawei Chen
This network shows the impact of papers produced by Dawei Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dawei Chen. The network helps show where Dawei Chen may publish in the future.
Co-authors
The 25 scholars most cited alongside Dawei Chen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 91 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Radiotherapy combined with immunotherapy: the dawn of cancer treatment Hit paper breakdown → | 2022 | 390 |
| 2 | Pembrolizumab with or without radiotherapy for metastatic non-small-cell lung cancer: a pooled analysis of two randomised trials Hit paper breakdown → | 2020 | 353 |
| 3 | 2020 | 182 | |
| 4 | 2020 | 97 | |
| 5 | 2020 | 81 | |
| 6 | 2020 | 72 | |
| 7 | 2013 | 70 | |
| 8 | 2020 | 69 | |
| 9 | 2020 | 63 | |
| 10 | 2021 | 63 | |
| 11 | 2019 | 57 | |
| 12 | Global burden of lung cancer in 2022 and projections to 2050: Incidence and mortality estimates from GLOBOCAN Hit paper breakdown → | 2024 | 55 |
| 13 | 2021 | 52 | |
| 14 | 2022 | 48 | |
| 15 | 2019 | 42 | |
| 16 | 2021 | 42 | |
| 17 | 2018 | 39 | |
| 18 | 2020 | 34 | |
| 19 | 2023 | 32 | |
| 20 | 2022 | 30 |
About Dawei Chen
Dawei Chen is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Molecular Biology, Immunology and Cancer Research, having authored 91 papers that have together received 2.4k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (32 papers), Lung Cancer Diagnosis and Treatment (22 papers), Lung Cancer Treatments and Mutations (19 papers), Lung Cancer Research Studies (16 papers), Immunotherapy and Immune Responses (11 papers), Inflammatory Biomarkers in Disease Prognosis (8 papers), Neuroendocrine Tumor Research Advances (6 papers) and Hepatocellular Carcinoma Treatment and Prognosis (5 papers). The work is most often cited by research in Oncology (1.5k citations), Pulmonary and Respiratory Medicine (933 citations), Immunology (554 citations), Cancer Research (323 citations) and Radiation (97 citations). Dawei Chen has collaborated with scholars based in China, United States and Türkiye. Frequent co-authors include Zengfu Zhang, Jinming Yu, Xu Liu, James W. Welsh, Vivek Verma, Hampartsoum B. Barsoumian, María Angélica Cortez, Roshal R. Patel, Joe Y. Chang and Jinming Yu. Their work appears in journals such as Frontiers in Oncology, Frontiers in Immunology, International Journal of Radiation Oncology*Biology*Physics, Journal of Clinical Oncology and Cancer Letters.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.